202 related articles for article (PubMed ID: 34686727)
1. Cumulative DNA damage by repeated low-dose cisplatin injection promotes the transition of acute to chronic kidney injury in mice.
Yamashita N; Nakai K; Nakata T; Nakamura I; Kirita Y; Matoba S; Humphreys BD; Tamagaki K; Kusaba T
Sci Rep; 2021 Oct; 11(1):20920. PubMed ID: 34686727
[TBL] [Abstract][Full Text] [Related]
2. Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
Landau SI; Guo X; Velazquez H; Torres R; Olson E; Garcia-Milian R; Moeckel GW; Desir GV; Safirstein R
Kidney Int; 2019 Apr; 95(4):797-814. PubMed ID: 30904067
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats.
Al Za'abi M; Al Salam S; Al Suleimani Y; Ashique M; Manoj P; Nemmar A; Ali BH
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):249-259. PubMed ID: 32936352
[TBL] [Abstract][Full Text] [Related]
4. Lethal (3) malignant brain tumor-like 2 (L3MBTL2) protein protects against kidney injury by inhibiting the DNA damage-p53-apoptosis pathway in renal tubular cells.
Huang H; Xu C; Wang Y; Meng C; Liu W; Zhao Y; Huang XR; You W; Feng B; Zheng ZH; Huang Y; Lan HY; Qin J; Xia Y
Kidney Int; 2018 Apr; 93(4):855-870. PubMed ID: 29276099
[TBL] [Abstract][Full Text] [Related]
5. Intratubular epithelial-mesenchymal transition and tubular atrophy after kidney injury in mice.
Yamashita N; Kusaba T; Nakata T; Tomita A; Ida T; Watanabe-Uehara N; Ikeda K; Kitani T; Uehara M; Kirita Y; Matoba S; Humphreys BD; Tamagaki K
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F579-F591. PubMed ID: 32799673
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.
Guo C; Pei L; Xiao X; Wei Q; Chen JK; Ding HF; Huang S; Fan G; Shi H; Dong Z
Kidney Int; 2017 Nov; 92(5):1194-1205. PubMed ID: 28709638
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cisplatin-induced injury in human kidney organoids.
Digby JLM; Vanichapol T; Przepiorski A; Davidson AJ; Sander V
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F971-F978. PubMed ID: 32150447
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity.
Orwick A; Sears SM; Sharp CN; Doll MA; Shah PP; Beverly LJ; Siskind LJ
Am J Physiol Renal Physiol; 2023 Mar; 324(3):F287-F300. PubMed ID: 36727944
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
Soni H; Kaminski D; Gangaraju R; Adebiyi A
Ren Fail; 2018 Nov; 40(1):314-322. PubMed ID: 29619879
[TBL] [Abstract][Full Text] [Related]
10. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity.
Li HY; Yang S; Li JC; Feng JX
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30455396
[TBL] [Abstract][Full Text] [Related]
11. Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
Guo X; Xu L; Velazquez H; Chen TM; Williams RM; Heller DA; Burtness B; Safirstein R; Desir GV
J Am Soc Nephrol; 2022 Feb; 33(2):342-356. PubMed ID: 34921111
[TBL] [Abstract][Full Text] [Related]
12. Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells.
Fu Y; Cai J; Li F; Liu Z; Shu S; Wang Y; Liu Y; Tang C; Dong Z
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1582-F1592. PubMed ID: 31532246
[TBL] [Abstract][Full Text] [Related]
13. The pathological role of Bax in cisplatin nephrotoxicity.
Wei Q; Dong G; Franklin J; Dong Z
Kidney Int; 2007 Jul; 72(1):53-62. PubMed ID: 17410096
[TBL] [Abstract][Full Text] [Related]
14. Numb ameliorates necrosis and inflammation in acute kidney injury induced by cisplatin.
Liu Z; Li Z; Chen Z; Li C; Lei L; Wu X; Li Y
Chem Biol Interact; 2020 Oct; 330():109251. PubMed ID: 32888910
[TBL] [Abstract][Full Text] [Related]
15. Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease.
Sharp CN; Doll MA; Megyesi J; Oropilla GB; Beverly LJ; Siskind LJ
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F161-F172. PubMed ID: 29384415
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.
Iwakura T; Zhao Z; Marschner JA; Devarapu SK; Yasuda H; Anders HJ
Nephrol Dial Transplant; 2019 Oct; 34(10):1669-1680. PubMed ID: 30624740
[TBL] [Abstract][Full Text] [Related]
17. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity.
Li S; Livingston MJ; Ma Z; Hu X; Wen L; Ding HF; Zhou D; Dong Z
JCI Insight; 2023 Apr; 8(8):. PubMed ID: 36917180
[TBL] [Abstract][Full Text] [Related]
18. DNA damage response in cisplatin-induced nephrotoxicity.
Zhu S; Pabla N; Tang C; He L; Dong Z
Arch Toxicol; 2015 Dec; 89(12):2197-205. PubMed ID: 26564230
[TBL] [Abstract][Full Text] [Related]
19. p53 in Proximal Tubules Mediates Chronic Kidney Problems after Cisplatin Treatment.
Fu S; Hu X; Ma Z; Wei Q; Xiang X; Li S; Wen L; Liang Y; Dong Z
Cells; 2022 Feb; 11(4):. PubMed ID: 35203361
[TBL] [Abstract][Full Text] [Related]
20. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury.
Wang Y; Tang C; Cai J; Chen G; Zhang D; Zhang Z; Dong Z
Cell Death Dis; 2018 Nov; 9(11):1113. PubMed ID: 30385753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
